Psoralidin, a major component of Psoraleae Fructus, induces inflammasome activation and idiosyncratic liver injury.

[1]  B. Salehi,et al.  Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action , 2020, Frontiers in Pharmacology.

[2]  Jiabo Wang,et al.  Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases , 2020, Cell Death & Disease.

[3]  Jiabo Wang,et al.  Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation , 2020, Acta pharmaceutica Sinica. B.

[4]  R. Zhou,et al.  The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases. , 2020, Advances in immunology.

[5]  Jiabo Wang,et al.  Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice , 2019, Archives of Toxicology.

[6]  Ming Niu,et al.  Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum , 2019, Archives of Toxicology.

[7]  Zhenlong Xin,et al.  Mechanisms explaining the efficacy of psoralidin in cancer and osteoporosis, a review. , 2019, Pharmacological research.

[8]  J. Uetrecht Mechanistic Studies of Idiosyncratic DILI: Clinical Implications , 2019, Front. Pharmacol..

[9]  Bo Li,et al.  Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: Inflammatory and oxidative stress playing important roles. , 2019, Journal of ethnopharmacology.

[10]  Jiabo Wang,et al.  New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions , 2019, Frontiers of Medicine.

[11]  R. Schwabe,et al.  NLR Family Pyrin Domain‐Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice , 2019, Hepatology.

[12]  N. Gekara,et al.  Biochemical and microscopic analysis of inflammasome complex formation. , 2019, Methods in enzymology.

[13]  P. Watkins Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications. , 2019, Advances in pharmacology.

[14]  Tao Li,et al.  Regulation of NLRP3 Inflammasome by Phosphorylation , 2018, Front. Immunol..

[15]  S. Wang,et al.  NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis , 2018, Clinical and experimental immunology.

[16]  K. Schroder,et al.  MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice , 2018, Scientific Reports.

[17]  J. Uetrecht,et al.  Editor’s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  J. Uetrecht,et al.  Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury , 2018, Journal of immunotoxicology.

[19]  Jiabin Xie,et al.  The Evaluation of Toxicity Induced by Psoraleae Fructus in Rats Using Untargeted Metabonomic Method Based on UPLC-Q-TOF/MS , 2017, Evidence-based complementary and alternative medicine : eCAM.

[20]  H. Xie,et al.  Calcitonin gene‐related peptide exerts anti‐inflammatory property through regulating murine macrophages polarization in vitro , 2017, Molecular immunology.

[21]  W. Xue,et al.  NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. , 2017, Molecular cell.

[22]  B. He,et al.  Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS‐mediated osteolysis by inhibiting inflammatory cytokines , 2017, International immunopharmacology.

[23]  F. Martinon,et al.  Inflammation in gout: mechanisms and therapeutic targets , 2017, Nature Reviews Rheumatology.

[24]  S. Hession,et al.  Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[25]  T. Kanneganti,et al.  Mechanisms governing inflammasome activation, assembly and pyroptosis induction , 2017, International immunology.

[26]  Michael Merz,et al.  Drug-induced liver injury: recent advances in diagnosis and risk assessment , 2017, Gut.

[27]  J. Uetrecht,et al.  Immune mechanisms of idiosyncratic drug-induced liver injury , 2017, Journal of clinical and translational research.

[28]  J. Uetrecht,et al.  Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury , 2017, Journal of immunotoxicology.

[29]  Rui-sheng Li,et al.  Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis , 2016, Front. Pharmacol..

[30]  Myung-Shik Lee,et al.  Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance , 2016, Archives of pharmacal research.

[31]  Jin-jian Lu,et al.  The Chemical Constituents and Bioactivities of Psoralea corylifolia Linn.: A Review. , 2016, The American journal of Chinese medicine.

[32]  B. K. Park,et al.  The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury , 2015, Human & experimental toxicology.

[33]  Rui-sheng Li,et al.  Inflammatory stress potentiates emodin-induced liver injury in rats , 2015, Front. Pharmacol..

[34]  G. Szabo,et al.  Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis. , 2015, Clinics and research in hepatology and gastroenterology.

[35]  Si Ming Man,et al.  Regulation of inflammasome activation , 2015, Immunological reviews.

[36]  F. Sutterwala,et al.  Mechanism of NLRP3 inflammasome activation , 2014, Annals of the New York Academy of Sciences.

[37]  A. Dhingra,et al.  Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: review. , 2013, Fitoterapia.

[38]  F. Sutterwala,et al.  Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. , 2013, Immunity.

[39]  Tao Wang,et al.  Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae. , 2012, Journal of ethnopharmacology.

[40]  J. Luyendyk,et al.  Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  S. Bursian,et al.  Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.